te Lupin: Today Latest News, Photos, Videos about Lupin - Zee Business

हिंदी में पढ़ें

Lupin

Lupin trades flat after launch of Bromfenac Ophthalmic Solution

Lupin trades flat after launch of Bromfenac Ophthalmic Solution

Wed, Jan 10, 2024

Lupin said that it was the exclusive first-to-file for Bromfenac Ophthalmic Solution, 0.07%, and is eligible for 180-day exclusivity.

BEL, L&T Finance Holdings, Lupin, Dabur: Stocks to watch on Friday

BEL, L&T Finance Holdings, Lupin, Dabur: Stocks to watch on Friday

Thu, Jan 04, 2024

Stocks to watch on Friday, January 5: Lupin got a receipt of tentative approval from the U.S. Food and Drugs Administration (USFDA) for Dapagliflozin and Saxagliptin tablets.

Lupin hits a 52-week high after Nomura's bullish stance; brokerage sees 21% upside

Lupin hits a 52-week high after Nomura's bullish stance; brokerage sees 21% upside

Tue, Jan 02, 2024

At around 9:55 a.m., shares of Lupin traded up by 4.51 per cent or Rs 59.2 at Rs 1371.85 apiece. The market capitalisation of the pharmaceutical company stood at Rs 62,457.14 crore at the same time.

TRENDING NOW

Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 crore

Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 crore

Fri, Dec 22, 2023

Lupin Atlantis Holdings SA, Switzerland, a wholly-owned subsidiary of the company, has signed an asset purchase agreement with Sanofi, a French multinational pharmaceutical and healthcare company, for the purpose, Lupin said in a regulatory filing.

Sun Pharma, Lupin recall drugs in US market: USFDA

Sun Pharma, Lupin recall drugs in US market: USFDA

Sun, Dec 17, 2023

Mumbai-based Sun Pharmaceutical Industries is recalling 96,192 bottles of Liothyronine Sodium Tablets in the US that are used to treat an underactive thyroid, according to the latest enforcement report issued by the American health regulator.

Stocks to watch out for today: Sugar stocks, Mazagon Dock, Lupin, PNB, Vedanta, NBCC

Stocks to watch out for today: Sugar stocks, Mazagon Dock, Lupin, PNB, Vedanta, NBCC

Fri, Dec 15, 2023

Stocks to watch on Monday, December 15: Mazagon Dock Shipbuilders Ltd (MDL) signed individual contracts with a European client for the construction of three units of 7,500 DWT multi-purpose hybrid powered vessels on December 14, 2023, for around $42 million.

D-Street Newsmakers: LIC, Bajaj Auto, Lupin among 10 stocks that hogged the limelight today

D-Street Newsmakers: LIC, Bajaj Auto, Lupin among 10 stocks that hogged the limelight today

Wed, Dec 06, 2023

Shares of the speciality chemicals company gained 12 per cent at Rs 2307.6 amid heavy volume in the counter.

Sun Pharma inks licensing pact with Aclaris Therapeutics

Sun Pharma inks licensing pact with Aclaris Therapeutics

Wed, Dec 06, 2023

Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases.

Lupin shares near 52-week high after drug maker receives two approvals from US regulator

Lupin shares near 52-week high after drug maker receives two approvals from US regulator

Fri, Nov 24, 2023

Lupin shares rose on Friday after the US drug regulator cleared two of the Mumbai-based pharmaceutical company's products.

Lupin shares clock 52-week high after 3.77-fold jump in Q2 net profit

Lupin shares clock 52-week high after 3.77-fold jump in Q2 net profit

Thu, Nov 09, 2023

Lupin share price NSE, Lupin result Q2 2023: Lupin shares rose on Thursday, November 9, as much as 1.7 per cent to clock a fresh 52-week high of Rs 1,232.1 apiece on the NSE.

Lupin gets FDA green signal for Mandideep facility; shares rise

Lupin gets FDA green signal for Mandideep facility; shares rise

Wed, Nov 01, 2023

Lupin shares were in demand on Wednesday after the drug maker received an establishment inspection report (EIR) from the US Food and Drug Administration (FDA) for its manufacturing facility in Mandideep, Madhya Pradesh.

Lupin stock rises after pharma major gets US FDA approval for its Tolvaptan tablets

Lupin stock rises after pharma major gets US FDA approval for its Tolvaptan tablets

Fri, Oct 06, 2023

Tolvaptan Tablets (RLD Jynarque®) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023), said Lupin.

Lupin inks pact to acquire 5 drug brands from Menarini for Rs 101 crore

Lupin inks pact to acquire 5 drug brands from Menarini for Rs 101 crore

Fri, Sep 22, 2023

Drug firm Lupin on Friday said it has inked a pact to acquire five drug brands from Italian firm Menarini for Rs 101 crore.

Lupin shares hit 52-week high after drug maker signs business transfer pact with subsidiary

Lupin shares hit 52-week high after drug maker signs business transfer pact with subsidiary

Tue, Sep 12, 2023

Lupin shares surged to a 52-week high on Tuesday, surpassing a peak touched last week, after the drug maker's board announced a business transfer agreement worth Rs 750-850 crore with its subsidiary, Lupin Manufacturing Solutions.

Lupin gets USFDA nod to market generic drug

Lupin gets USFDA nod to market generic drug

Fri, Aug 25, 2023

Drug maker Lupin on Friday said it has received approval from the US health regulator to market a generic product, used in the treatment of a lung disease, in the American market.

Lupin shares hit fresh 52-week high on the back of drug launch and USFDA approval

Lupin shares hit fresh 52-week high on the back of drug launch and USFDA approval

Thu, Aug 17, 2023

Pharmaceutical company Lupin has hit a new 52-week high price on the back of the launch of its generic drug to combat Chronic Obstructive Pulmonary Disease (COPD) as well as receiving approval from USFDA for another drug.

USFDA concludes inspection at Lupin’s Madhya Pradesh unit with no observations, stock gains over 2%

USFDA concludes inspection at Lupin’s Madhya Pradesh unit with no observations, stock gains over 2%

Mon, Aug 14, 2023

In July, the pharma company announced that the US drug regulator inspected its Nagpur oral solid dosage facility from July 3 to July 11, 2023. The inspection was closed with the issuance of a Form-483 with two observations.

Lupin gains on USFDA nod for body oil used in treating skin problems

Lupin gains on USFDA nod for body oil used in treating skin problems

Wed, Aug 09, 2023

This product will be manufactured at Lupin's Somerset facility in the US. This medication is indicated for treating eczema, a skin condition that causes red, irritated, and itchy skin.

Lupin gets USFDA nod to market generic skin treatment medication

Lupin gets USFDA nod to market generic skin treatment medication

Wed, Aug 02, 2023

New Jersey-based Novel Laboratories Inc has received the approval from the US Food and Drug Administration (USFDA) for Fluocinolone Acetonide Topical Oil, Lupin said in a statement.

Lupin unit introduces inhaler for asthma patients in Germany

Lupin unit introduces inhaler for asthma patients in Germany

Fri, Jul 21, 2023

Lupin news: Drug firm Lupin on Friday said its unit has launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in Germany.

Lupin Vizag facility gets US regulator's inspection report with no observations

Lupin Vizag facility gets US regulator's inspection report with no observations

Mon, Jun 19, 2023

The US drug regulator its inspection, carried out from March 6 to March 10, at the Indian company's Vizag facility with a "no action indicated", according to a company statement.

Lupin eyes Rs 2,500-crore market with its latest launch in US; what Anil Singhvi recommends

Lupin eyes Rs 2,500-crore market with its latest launch in US; what Anil Singhvi recommends

Mon, Jun 05, 2023

Zee Business Managing Editor Anil Singhvi said he remained upbeat on Lupin shares on account of the company's positive business outlook.

Stocks to buy: IRCTC, Titan, Bharat Forge among analysts' top picks

Stocks to buy: IRCTC, Titan, Bharat Forge among analysts' top picks

Tue, May 30, 2023

Stocks to buy today, Pick of the Day: In conversation with Zee Business Managing Editor Anil Singhvi, market experts Himanshu Gupta, Rakesh Bansal, Kunal Saraogi, Sumeet Bagadia, Avinash Gorakshakar and Sandeep Wagle share their top recommendations for the day in this special segment, Pick of the Day.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x